Ghana Synjardy Launch

The Ghana Synjardy Launch is a high-impact hybrid Continuing Professional Development (CPD) training and product launch event designed to advance the management of Type 2 Diabetes Mellitus (T2DM) in contemporary clinical practice. This session brings together distinguished endocrinology experts who will deliver insightful, evidence-based presentations tailored to both global guidelines and the Ghanaian clinical context.

The programme will explore the evolving role of early and effective therapeutic strategies, with particular emphasis on combination therapy using empagliflozin and metformin. Participants will gain valuable perspectives on optimizing glycaemic control while addressing cardiovascular and renal risk factors—key considerations in modern diabetes care. With a strong focus on real-world application, this interactive session promises to be informative, practical, and engaging.

WHY YOU SHOULD ATTEND

1. Stay updated on current guideline-based approaches to managing Type 2 Diabetes

2. Gain insights into the Ghanaian perspective and real-world clinical practice

3. Understand the role of early combination therapy in improving outcomes

4. Learn about cardio-renal-metabolic protection strategies in diabetes care

5. Engage directly with leading endocrinologists and clinical experts

6. Earn CPD points accredited by the Medical and Dental Council (MDC)

SUMMARY OF PRESENTATION TOPICS

Session 1: Welcome & Introduction

i. Opening remarks and overview of the programme by sponsors

Session 2: Managing Diabetes – Guideline-Based and Ghanaian Perspective

i. Overview of global diabetes management guidelines

ii. Adaptation to local clinical realities in Ghana

iii. Addressing challenges in routine practice

Session 3: Combination Therapy in Type 2 Diabetes

i. Clinical rationale for empagliflozin + metformin combination

ii. Benefits in drug-naïve patients

iii. Impact on glycaemic control and cardio-renal outcomes

Session 4: Interactive Q&A / Panel Discussion

i. Audience engagement and expert responses

ii. Clarification of key clinical concepts

Session 5: Official Launch

i. Introduction and unveiling of Synjardy

EVENT HIGHLIGHTS

i. Expert-led sessions by renowned endocrinologists

ii. Focus on practical, real-world diabetes management

iii. Insight into innovative combination therapy

iv. Interactive Q&A and panel discussion

v. Official product launch segment

vi. Opportunity to earn CPD-accredited learning points

PARTICIPANT CONSENT AND DATA PRIVACY NOTICE

By registering for the “Ghana Synjardy Launch”, you consent to participate in this training hosted by CES on behalf of Boehringer Ingelheim and DP World. Your registration will provide us with the necessary information to facilitate the event and issue CPD accreditation through the Medical and Dental Council (MDC) and Pharmacy Council (PC).

Please note that CES is committed to safeguarding your personal information and will not share any personal data with Boehringer Ingelheim and DP World. Your data will only be shared with the relevant regulatory bodies, such as MDC & PC, for the sole purpose of accrediting you with CPD points earned through this training.

Additionally, participants are free to opt out of the meeting at any time, and should you wish to do so, no further action is required on your part. We respect your privacy and ensure that your participation will be treated with the highest level of confidentiality.

PROUDLY SPONSORED BY

This is a hybrid event. The CPD event will be streamed LIVE on this page.

Date:  Wed. 29th April, 2026

Time: 1730 GMT (5:30pm local time)

Target Audience: Medical Doctors & Pharmacists

In-person attendance is STRICTLY BY INVITATION at the Accra City Hotel, Accra.

Don’t miss out on this exciting opportunity to elevate your skills and make a lasting impact!